Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

HLA-identical sibling stem-cell transplantation in first-remission AML.

Ailawadhi S, Padmanabhan S.

Blood. 2007 Dec 15;110(13):4619; author reply 4619-20. No abstract available.

2.

Is there a role for autotransplants in AML in first remission?

Seshadri T, Keating A.

Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):17-20. doi: 10.1016/j.bbmt.2008.11.016. Review.

3.

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years.

Giebel S, Labopin M, Holowiecki J, Labar B, Komarnicki M, Koza V, Masszi T, Mistrik M, Lange A, Hellmann A, Vitek A, Pretnar J, Mayer J, Rzepecki P, Indrak K, Wiktor-Jedrzejczak W, Wojnar J, Krawczyk-Kulis M, Kyrcz-Krzemien S, Rocha V.

Ann Hematol. 2009 Oct;88(10):1005-13. doi: 10.1007/s00277-009-0719-5. Epub 2009 Mar 20.

PMID:
19301005
4.

Place of HSCT in treatment of childhood AML.

Klingebiel T, Reinhardt D, Bader P; EBMT Paediatric Diseases Working Party..

Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S7-9. doi: 10.1038/bmt.2008.276. Review.

PMID:
18978749
5.

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.

Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.

Biol Blood Marrow Transplant. 2008 Jun;14(6):651-7. doi: 10.1016/j.bbmt.2008.03.006.

6.

[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].

Dou LP, DA WM, Zhao DD, Wang C, Lu XC, Kang HY, Yan P, Wang FF, Zhu HY, Li HH, Gao CJ, Yu L.

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3111-4. Chinese.

PMID:
18269867
7.

[Treatment for AML in first remission].

Miyazaki Y.

Rinsho Ketsueki. 2010 Jul;51(7):471-6. Review. Japanese. No abstract available.

PMID:
20693765
8.
9.

Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.

Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.

Biol Blood Marrow Transplant. 2008 Feb;14(2):181-6. doi: 10.1016/j.bbmt.2007.09.017. Epub 2007 Dec 31.

10.

Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.

Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V; Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation..

Haematologica. 2008 Jun;93(6):834-41. doi: 10.3324/haematol.11277. Epub 2008 May 10.

11.

High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.

Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W, Kolb HJ.

Bone Marrow Transplant. 2008 Apr;41(8):721-7. doi: 10.1038/sj.bmt.1705965. Epub 2008 Jan 7.

PMID:
18176613
12.

Hematopoietic stem cell transplantation in adults with acute myeloid leukemia.

Hamadani M, Awan FT, Copelan EA.

Biol Blood Marrow Transplant. 2008 May;14(5):556-67. doi: 10.1016/j.bbmt.2008.02.019. Review.

14.

Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.

Cahu X, Mohty M, Faucher C, Chevalier P, Vey N, El-Cheikh J, Guillaume T, Furst S, Delaunay J, Ayari S, Moreau P, Gastaut JA, Harousseau JL, Blaise D.

Bone Marrow Transplant. 2008 Nov;42(10):689-91. doi: 10.1038/bmt.2008.231. Epub 2008 Aug 4. No abstract available.

PMID:
18679370
15.

Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.

Craddock CF.

Bone Marrow Transplant. 2008 Mar;41(5):415-23. doi: 10.1038/sj.bmt.1705975. Epub 2008 Jan 21. Review.

PMID:
18209726
16.

Alternative donor transplants for high-risk acute myeloid leukemia.

Gupta V.

Curr Opin Hematol. 2008 Mar;15(2):115-20. doi: 10.1097/MOH.0b013e3282f3de99. Review.

PMID:
18300757
17.

Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.

Lee DH, Kwon YJ, Lim J, Kim Y, Han K, Chung NG, Jeong DC, Cho B, Kim HK.

Pediatr Transplant. 2009 Mar;13(2):210-6. doi: 10.1111/j.1399-3046.2008.00997.x. Epub 2008 Jul 1.

PMID:
18627512
18.

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.

Schetelig J, Bornhäuser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, Stelljes M, Hegenbart U, Schäfer-Eckart K, Füssel M, Wiedemann B, Thiede C, Kienast J, Baurmann H, Ganser A, Kolb HJ, Ehninger G.

J Clin Oncol. 2008 Nov 10;26(32):5183-91. doi: 10.1200/JCO.2007.15.5184. Epub 2008 Sep 2.

PMID:
18768435
19.

Pediatric standard-risk AML with fully matched sibling donors: to transplant in first CR or not?

Gassas A, Afzal S, Ishaqi MK, Finkelstein-Shechter T, Rojas M, Dupuis A, Sung L, Doyle J.

Bone Marrow Transplant. 2008 Sep;42(6):393-6. doi: 10.1038/bmt.2008.182. Epub 2008 Jun 30.

PMID:
18587434
20.

Treatment of relapsing AML following hematopoietic stem cell transplantation.

Atlas MP, Lipton JM.

Pediatr Transplant. 2003 Dec;7(6):419-21. No abstract available.

PMID:
14870887

Supplemental Content

Support Center